Cabaletta Bio, Inc.

Late-stage cell-therapy biotech developing rese-cel as a one-time immune-reset approach across autoimmune diseases.

Back to company catalog

Autoimmune disease · Autologous CD19 CAR-T cell therapy · Registrational / late clinical

Compare report options